Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
Marinus Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:30pm, Monday, 12'th Apr 2021
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS--MARINUS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Marinus Pharmaceuticals Appoints Dr. Saraswathy (Sara) Nochur to Board of Directors
07:00am, Wednesday, 24'th Mar 2021
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #BOD--Marinus Pharmaceuticals Appoints Dr. Saraswathy (Sara) Nochur to Board of Directors
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 12'th Feb 2021
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MRNS--Marinus today announced the grant of inducement awards to five new employees.
Marinus Pharmaceuticals to Provide Business Update and Announce Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
07:31am, Wednesday, 10'th Feb 2021
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #earnings--Marinus Pharmaceuticals will release the financial results for the fourth quarter and fiscal year ended December 31, 2020 on March 9 via webcast.
Marinus (MRNS) Gets Positive FDA Response for Ganaxolone Study
11:17am, Thursday, 14'th Jan 2021
Marinus (MRNS) gets positive FDA response for phase III Marigold study on oral ganaxolone in children and young adults with CDKL5 deficiency disorder that appears sufficient to support the NDA filing.
RADNOR, Pa.--(BUSINESS WIRE)-- #CDD--Marinus received a positive response from the FDA on sufficiency of Marigold Study data to support filing of NDA for the use of ganaxolone in CDD.
5 Disruptive Biotech Stocks With Solid Long-Term Potential
10:41am, Monday, 04'th Jan 2021
Here we discuss five biotech stocks - EDIT, VRTX, NTLA, CBAY, MRNS - that could prove to be great investments in the long run.
Marinus Pharmaceuticals Announces Its Addition to the Nasdaq Biotechnology Index
07:02am, Monday, 21'st Dec 2020
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus Pharmaceuticals announced it has been selected for inclusion in the Nasdaq Biotechnology Index (NBI).
Why Shares of iBio, Marinus Pharmaceuticals, and Arcturus Therapeutics All Crashed on Tuesday
06:20pm, Tuesday, 08'th Dec 2020
This can happen when a company holds out its hand for a big chunk of fresh capital.
Marinus Pharmaceuticals Announces Pricing of $70 Million Public Offering of Common Stock
09:35am, Tuesday, 08'th Dec 2020
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus Pharmaceuticals announces the pricing of an underwritten public offering of 5 million shares of its common stock for gross proceeds of $7
RADNOR, Pa.--(BUSINESS WIRE)-- #AES2020--Marinus Pharmaceuticals will provide additional ganaxolone data during #AES2020 Scientific Exhibit.
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:57pm, Friday, 04'th Dec 2020
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals announced the grant of inducement awards to two new employees.
Marinus Pharmaceuticals Announces Four Presentations on Ganaxolone at AES2020 Virtual Annual Meeting
01:43pm, Monday, 23'rd Nov 2020
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #AES2020--Marinus Pharma. to present updates and data from its trials in CDKL5 and refractory status epileptics at American Epilepsy Society's conference.
Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q3 2020 Results - Earnings Call Transcript
11:10pm, Monday, 09'th Nov 2020
Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q3 2020 Results - Earnings Call Transcript
Epilepsy Pipeline Review 2020: Therapeutic Analysis Report Featuring 140+ Companies & Drug Profiles - ResearchAndMarkets.com
12:00am, Tuesday, 13'th Oct 2020
The
